Gastric contents alter blood alcohol levels and clearance after parenteral ethanol

Binge ethanol drinking during adolescence modifies cocaine responses in mice

Binge ethanol drinking is an emerging pattern of excessive consumption among adolescents and young adults. Repeated ethanol intoxication has negative consequences during critical periods of brain development. Therefore, binge ethanol intake represents a vulnerability factor that promotes subsequent manifestations of neuropsychiatric disorders. In this study, we investigated the effects of oral binge ethanol intake during adolescence on the subsequent effects of cocaine in C57BL/6 mice. Firstly, we evaluated the oral ethanol intake of two binge ethanol procedures with different ethanol concentrations (20% v/v versus 30%, v/v). The highest ethanol intake was found in mice exposed to the lower ethanol concentration (20% v/v). In a second experiment, mice exposed to binge ethanol procedure were evaluated to study the effects of cocaine on locomotor activity, behavioural sensitization, and the reinforcing effects of cocaine in the self-administration paradigm. Mice exposed to ethanol binging showed discrete detrimental effects in responses to cocaine in the different experiments evaluated. Our findings revealed that the pattern of binge ethanol consumption in adolescent mice here evaluated produced a weak facilitation of cocaine responses. The present study highlights the importance of interventions to limit the deleterious effects of binge ethanol drinking during adolescence.

Altered oral absorption of alcohol by combined aqueous extracts of four herbal plants in rats

This study examined the effect of combined aqueous extracts (BHR) of Ginko biloba, Mentha arvensis var. piperascens, Citrus unshiu, and Pueraria lobata var. chinensis on oral absorption of alcohol in rats. The rats were pretreated with BHR, placebo solution identical to BHR without the herbal extract, and isotonic saline. Alcohol was administered orally at 1- and 3-g/kg doses and the absorption profiles were compared. After oral administration of 1-g/kg doses, mean area under the curve (AUC) and C(max) values were significantly reduced in BHR-treated rats (16.1 +/- 10.0 and 0.3 +/- 0.1 mg/ml, respectively) as compared with saline-treated (37.9 +/- 14.4 and 0.7 +/- 0.7 mg/ml, respectively) and placebo solution-treated (63.0 +/- 46.4 and 0.7 +/- 0.4 mg/ml, respectively) rats. Similarly, after administration of 3-g/kg doses, mean AUC and C(max) values in BHR-treated rats (188.1 +/- 119.7 mg(.)min/ml and 1.0 +/- 0.4 mg/ml) were significantly reduced over those in saline-treated rats (571.4 +/- 512.4 mg(.)min/ml and 1.8 +/- 0.9 mg/ml, respectively). The relative oral bioavailability of alcohol calculated as the ratio of AUC(BHR)/AUC(Saline) was 42.5% and 32.9% at 1- and 3-g/kg doses, respectively. The reduced serum alcohol levels as well as the reduced AUC and C(max) after pretreatment with BHR appear to be a result of a reduced systemic absorption not due to an increased metabolic clearance.

Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects

INTRODUCTION

Alcohol induces disturbances in insulin-like growth factor-I (IGF-I) and IGF binding protein-1 (IGFBP-1) levels. The aim of the present study was to compare pure ethanol and alcopop effects on total and free IGF-I, IGFBP-1, IGF-I:IGFBP-1 complex, insulin and plasma glucose levels in healthy subjects.

METHODS

Five males and seven females (21-51 years) consumed pure ethanol and alcopops with identical alcohol content in a cross-over design after 6h fasting. Blood samples were obtained for determination of serum ethanol and plasma glucose at 0, 30, 60, 90, 120 and 180 min. Serum total and free IGF-I, IGFBP-1, IGF-I:IGFBP-1 complex, and insulin were measured at 0, 60 and 180 min.

RESULTS

Area under the curve for serum ethanol concentration was significantly less following alcopop compared to pure ethanol (1124+/-201 vs. 1691+/-359 mmol/Lh, P<0.01). Serum insulin and glucose levels were unchanged by ethanol while alcopop intake was followed by a transient increase in glucose and insulin levels (P<0.05). Pure ethanol and alcopop reduced free IGF-I levels by the end of the study period (P=0.05). IGFBP-1 and the IGF-I:IGFBP-1 complex increased following ethanol intake (P<0.05) while only a small transient IGFBP-1 increase was observed following alcopop intake. No change in total IGF-I was observed.

CONCLUSION

Both drinks resulted in reduced free IGF-I levels, however, only pure ethanol increased IGFBP-1 and the IGF-I:IGFBP-1 complex. Alcopop intake was associated with a transient increase in IGFBP-1 and unchanged IGF-I:IGFBP-1 complex levels probably due to marked changes in insulin and glucose levels.

Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis

The present study compared the effect of different modes of alcohol administration on the activity of the hypothalamic-pituitary-adrenal (HPA) axis. In a first series of studies, we investigated the influence of the intraperitoneal (ip) and intragastric (ig) effect of acutely administered alcohol. Over a 3-hr period, alcohol induced dose-related increases in adrenocorticotropic hormone (ACTH) and alcohol levels in the circulation. There was a good correlation between blood ACTH and alcohol levels (ip treatment, R = 0.84; ig treatment, R = 0.79). Measurement of steady-state mRNA of the immediate early gene NGFI-B, taken as an index of neuronal activation in the paraventricular nucleus (PVN) of the hypothalamus of rats administered 3 g of alcohol/kg, indicated significant (p < 0.01) increases between 60 and 180 min after both ip and ig alcohol injection, with peak stimulation at 1 and 2 hr, respectively. Although NGFI-B mRNA levels had returned to control level in the parvicellular portion of the PVN of animals administered the drug ip 4 hr earlier, they were still significantly (p < 0.01) elevated 4 hr after ig treatment. A second series of studies used rats fed an alcohol diet containing 6.4% alcohol (w/v), or pair-fed. The rats were tested during the 4th or 6th night of treatment. Despite blood alcohol levels ranging between 0.060 and 0.140% w/v, there was no significant rise in plasma ACTH/corticosterone levels in animals fed the drug, and no detectable NGFI-B mRNA in their PVN. Collectively, these results indicate that both the ip and the ig acute injection of alcohol induced dose-related increases in plasma ACTH levels. PVN neuronal activation was also observed. In contrast, the alcohol diet had no effect on HPA hormone levels or PVN expression of NGFI-B.

Bioavailability of ethanol is reduced in several commonly used liquid diets

Liquid diets are often used as a vehicle for chronically treating laboratory animals with ethanol. However, a recent report suggested that one or more components of these diets may bind ethanol which could result in a decrease in the bioavailability of ethanol. Consequently, we compared the blood ethanol concentration vs. time curves obtained following the intragastric (i.g.) administration of ethanol dissolved in water or in one of three liquid diets (Bioserv AIN-76, Sustacal, or Carnation Slender) using the long-sleep (LS) and short-sleep (SS) mouse lines. The initial rates of absorption were generally the same for the water-ethanol and diet-ethanol groups, but the diets generally produced lower peak levels and the areas under the ethanol concentration-time curves were less for all of the liquid diets than for the control, ethanol-water solution. In vitro dialysis experiments indicated that the Bioserv diet binds ethanol in a saturable manner. Therefore, it may be that the slower release of ethanol, which should occur as a result of binding, serves to increase the role of first pass metabolism in regulating ethanol concentrations following oral administration. Because the effects of the diets were seen even after pyrazole treatment, it may be that the lower blood ethanol levels arise because metabolism by gastric ADH, rather than hepatic ADH, is responsible for a major portion of ethanol metabolism as ethanol is slowly released by the diets. If so, the observation that the diet/water differences were uniformly greater in the LS mice may indicate that LS-SS differences in gastric ADH exist.(ABSTRACT TRUNCATED AT 250 WORDS)

Genotype regulates the development of tolerance to ethanol and cross-tolerance to nicotine

The long-sleep (LS) and short-sleep (SS) mouse lines were selectively bred for differential sensitivity to the anesthetic actions of ethanol, but they also differ in sensitivity to nicotine. A recent study suggested that the LS mice develop more tolerance to ethanol and cross-tolerance to nicotine than do the SS following chronic ethanol treatment. The studies reported here expand on these previous studies by assessing potential tolerance to ethanol and cross-tolerance to nicotine using additional behavioral and physiological measures. In addition, the effects of chronic ethanol treatment on ethanol and nicotine metabolism were measured. The LS mice developed tolerance to ethanol as measured by effects on open-field activity, body temperature, and sleep time, whereas the SS mice did not develop consistent tolerance to ethanol's effects on any of these measures. Cross-tolerance to nicotine's effects on open-field activity and body temperature developed, but only in the LS mice. The ethanol tolerance is likely due to changes in CNS sensitivity to ethanol, but altered elimination of nicotine may explain much of the cross-tolerance to nicotine seen in chronic ethanol-treated LS mice.

Lowering of blood ethanol by activated carbon products in rats and dogs

Earlier studies on the effects of activated carbon (charcoal) on blood alcohol levels (BAL) in animals have been conflicting. The present study was designed to study the effects of a commercially available product (Charcoaid) and a new patented product (Alcosorb), in capsules and in suspension on the BAL of rats and dogs. We compared peak BAL and the regression of BAL with time during ethanol clearance in rats given 1.5 g/kg of carbon products in sorbitol intragastrically, followed 5 min later by 3.5 g/kg ethanol intragastrically. Peak BAL were significantly higher after Charcoaid 1 h after intubation, compared to Alcosorb and sorbitol (vehicle for the charcoal suspension). A study in which ethanol was given intraperitoneally instead of intragastrically showed no differences in ethanol BAL produced by the intragastric carbon treatments. In a crossover study using Beagle dogs, 780 mg capsules of carbon products ("low dose") given 5 min before ethanol had no significant effect on BAL. A "high" dose of 20 g of charcoal products suspended in water, followed by ethanol intragastrically, was also ineffective in lowering blood ethanol. However, carbon products suspended in a water/ethanol vehicle (20% w/v) did significantly lower peak BAL. We conclude that carbon products significantly lower BAL in rats and dogs, and that in rats, Alcosorb and sorbitol produce a greater BAL lowering effect than Charcoaid for a brief time after administration. The mechanisms of the BAL lowering effect by sorbitol and charcoal products are probably different.

Omega-conotoxin increases sleep time following ethanol injection

omega-Conotoxin and ethanol produce similar actions on in vitro calcium channel functions. The present study was designed to determine their possible behavioral interaction. omega-Conotoxin injected ICV at either 0.1 microgram or 0.3 microgram, produced an increase in spontaneous and evoked tremor activity in male Sprague-Dawley rats. The tremor was present at 30 min and continued at least 4 h after injection. At 4 h post ICV injection, animals were given an IP injection of ethanol (3 g/kg body weight). Although no blood alcohol differences were observed between groups, rats injected with omega-conotoxin showed a concentration-dependent increase in sleep times: Saline controls slept for an average of 84.7 +/- 16.7 min, 0.1 and 0.3 microgram conotoxin treated animals slept for 121.3 +/- 16.2 and 211.1 +/- 30.7 min, respectively. These results extend the class of calcium channel blockers capable of producing a behavioral interaction with ethanol.

In vivo microdialysis study of brain ethanol concentrations in rats following oral self-administration

Using intracerebral microdialysis, the time-course of ethanol absorption was determined in the striatum of rats after oral self-administration of an ethanol solution. Microdialysis samples were collected every 10 min for 1 hr before and 1 hr after consumption of ethanol over a 5-min period. Substantial levels of ethanol were detected in the brain in the first sample taken after self-administration although these levels did not correlate with the amount of ethanol consumed. Striatal ethanol levels reached maximum or near maximum by the second sample and remained constant for the time points between 20 and 60 min; at these times, brain ethanol levels correlated significantly with the amount consumed. This study demonstrates that oral consumption of ethanol leads to measurable brain levels within a relatively short time. Results suggest that experimental animals may experience the central effects of ethanol during the course of drinking and this could play a role in alcohol preference or avoidance behavior.

The effects of chronic ethanol exposure on N-methyl-D-aspartate-stimulated overflow of [3H]catecholamines from rat brain

The effects of acute and chronic ethanol administration on N-methyl-D-aspartate-stimulated catecholamine overflow were examined. Three groups of male Sprague-Dawley rats were used. The first group received a chronic liquid diet containing ethanol (37%) for 3 weeks. The second group was pair-fed a liquid diet with dextrin substituted for ethanol isocalorically. The third group received Purina rat lab chow and water ad libitum. N-methyl-D-aspartate-stimulated [3H]catecholamine overflow from brain tissue slices was determined. N-methyl-D-aspartate (50-2000 microM) produced a concentration-dependent increase in [3H]norepinephrine overflow from cortical and hippocampal slices with no significant alteration of the response following chronic ethanol treatment. [3H]Dopamine overflow from striatal slices of the chronic ethanol group was significantly different at 1000 microM N-methyl-D-aspartate. The response of the chronic ethanol-treated group at the 1000 microM N-methyl-D-aspartate concentration was 30% and 40% lower than the pair-fed and ad libitum controls, respectively. Ethanol when added in vitro (30-200 mM) produced a concentration-dependent inhibition of N-methyl-D-aspartate (150 microM) stimulated efflux in all brain regions, and chronic ethanol treatment did not alter the inhibitory response. These results indicate an apparant lack of adaptation in N-methyl-D-aspartate-stimulated transmitter release following chronic ethanol treatment in this particular paradigm.

Effects of ethanol and delta 9-tetrahydrocannabinol on phencyclidine disposition in dogs

A three-way crossover study was performed to determine the influence of delta 9-tetrahydrocannabinol (THC) and ethanol (EtOH) separately upon phencyclidine (PCP) disposition in dogs. Seven dogs were given three single dose treatments: 1.5 mg PCP kg-1 i.v., 1.5 mg PCP kg-1 i.v. with 0.4 mg kg-1 THC i.v., and 1.5 mg PCP kg-1 i.v. with 1.25 g EtOH kg-1 i.v. PCP was measured in plasma samples collected for 24 h after administration of each treatment, with several pharmacokinetic parameters calculated from the plasma concentration vs time data. The PCP serum Cls values were significant change in V beta or t1/2. EtOH did not induce significant changes in any PCP pharmacokinetic parameter, although mean Cls and V beta were increased. These results confirm the observed THC inhibition of PCP metabolism, and suggest that the enhanced pharmacologic action of PCP by THC may result from higher serum PCP concentrations. These results further suggest that enhanced PCP actions by acute EtOH administration may result from increased PCP distribution to the CNS.